Benzinga's Top #PreMarket Losers
September 29, 2015 at 08:22 AM EDT
Esperion Therapeutics Inc (NASDAQ: ESPR) shares fell 13.94 percent to $30.20 in pre-market trading following an update on ETC-1002 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.